Work

Evaluation of D-dimer Levels for the Differential Diagnosis of Acute Chest Pain in Hong Kong: A Single-Centre Retrospective Study D-dimer for Chest Pain Diagnoses

Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background D-dimer is elevated in acute aortic syndrome (AAS) and pulmonary embolism (PE), but local comparative data is limited. This study explores D-dimer's diagnostic value for AAS to inform acute chest pain management. Methods This retrospective single-centre study in Hong Kong evaluated adult emergency department (ED) patients presenting with chest pain between 2020 and 2025. Patients with D-dimer testing were grouped by diagnosis: AAS, PE, ischaemic heart disease (IHD), or non-specific chest pain (CP). Outcomes included D-dimer levels, diagnostic performance of D-dimer for AAS and PE, computed tomography (CT) utilization, 7- and 30-day mortality, hospital length of stay, and 28-day readmission rates. Results Among 1,019 included patients, median D-dimer levels were 329, 531, 3738, and 4693 ng/mL for CP, IHD, PE, and AAS, respectively. The AUROC for distinguishing AAS from non-AAS was 0.84 (95% CI: 0.79–0.89). D-dimer ≥ 2000 ng/mL was associated with significantly higher mortality. ED-based CT scans were performed in only 3 (27.3%) of AAS and 15 (6.3%) of PE patients. Conclusions This study reports the first local data characterising D-dimer levels across acute chest pain aetiologies, with the highest values observed in AAS and PE. The notably low CT rates in both the AAS and PE groups highlight an unanswered clinical need, and prospective multicentre studies integrating biomarkers with validated clinical decision tools are warranted to optimise risk stratification and CT utilisation for high-risk ED patients with chest pain.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7236580051
Cites: 16
Cited by:
Related to: 10